1 Min Read
April 24 (Reuters) - Onxeo SA:
* Clinigen and co initiate managed access programme for belinostat in Europe for patients with peripheral T-cell lymphoma (PTCL) Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.